High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile | Zendy

Denise Drudy | Zendy; Teresa Quinn | Zendy; Rebecca O’Mahony | Zendy; Lorraine Kyne | Zendy; Peadar Ó Gaora | Zendy; Séamus Fanning | Zendy

Open Access

High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile

Author(s) -

Denise Drudy,

Teresa Quinn,

Rebecca O’Mahony,

Lorraine Kyne,

Peadar Ó Gaora,

Séamus Fanning

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl398

Subject(s) - gatifloxacin , clostridium difficile , microbiology and biotechnology , moxifloxacin , toxin , clostridium difficile toxin a , pore forming toxin , clostridium difficile toxin b , clostridiaceae , biology , antibiotics , microbial toxins , levofloxacin

To determine the mechanism of high-level resistance to fluoroquinolone antimicrobials in toxin-A-negative, toxin-B-positive (A- B+) Clostridium difficile isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research